FindTrial
Sign In

Retrospective investigative analysis in effectiveness and adverse effects of HLA-matched platelet concentrates

Retrospective investigative analysis in effectiveness and adverse effects of HLA-matched platelet concentrates - Retrospective observation of HLA-matched platelet concentrates

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000054113
Enrollment
100
Registered
2024-05-01
Start date
2024-04-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PC-HLA supplied from Japan red cross from 2000/1/1 to 2023/12/31.

Interventions

None listed

Sponsors

Saitama medical university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients who HLA matched platelet concentrates were transfused.

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

MeasureTime frame
Efficacy and safety of PC-HLA—

Secondary

MeasureTime frame
Factors affected to the efficacy of PC-HLA and suitability coincidence with guideline—

Countries

Japan

Contacts

Public ContactAkaru Ishida

International medical center, Saitama medical university Division of transfusion and cell transplantation

aishida@saitama-med.ac.jp+81367656888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026